Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.

Khitam MuhsenNimrod MaimonAmi MizrahiOmri BodenneimerDani CohenMichal MaimonItamar GrottoRon Dagan

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

VE following two doses of BNT162b2 against SARS-CoV-2 acquisition in LTCF HCWs was high. The lower viral loads among SARS-CoV-2 positive HCWs suggests further reduction in transmission.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
coronavirus disease
binding protein